AbbVie’s not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and moreAllbiopro2018-09-26T11:20:09+09:009월 26th, 2018|
Arena 3 for 3 as Crohn’s drug meets proof-of-concept testAllbiopro2018-09-26T11:19:40+09:009월 26th, 2018|
Reata’s bardoxolone hits goals in phase 2 kidney disease trialAllbiopro2018-09-26T11:18:49+09:009월 26th, 2018|
Scientists have discovered how to predict life of implants without animal testingAllbiopro2018-09-26T11:17:57+09:009월 26th, 2018|
Study of protein ‘trafficker’ provides insight into autism and other brain disordersAllbiopro2018-09-26T11:17:30+09:009월 26th, 2018|
First direct 3D maps of water during cell membrane fusionAllbiopro2018-09-26T11:17:02+09:009월 26th, 2018|
Nothing Fishy Here: Amarin’s Fish Oil-Based Drug Dramatically Reduces Cardiovascular RiskAllbiopro2018-09-25T11:16:46+09:009월 25th, 2018|
Some Cancer Cells Hide From Immunotherapy Treatments, Study FindsAllbiopro2018-09-25T11:15:55+09:009월 25th, 2018|
AstraZeneca’s Diabetes Drug Farxiga Decreases Risk of Cardiovascular DiseaseAllbiopro2018-09-25T11:14:12+09:009월 25th, 2018|
A Look at 7 Upcoming and Recently Announced Biotech IPOsAllbiopro2018-09-25T11:13:20+09:009월 25th, 2018|
After Stumbling with Waylivra, Akcea Therapeutics’ Lipid Drug Shows PromiseAllbiopro2018-09-25T11:12:28+09:009월 25th, 2018|
